Mast Therapeutics, Inc.(NYSE Amex Equities : MSTX)
MSTX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
Loading MSTX News...
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.24%||67.26||1.0%||$568.09m|
|REGN||Regeneron Pharmaceuticals, Inc.||3.03%||394.14||2.1%||$385.16m|
|VRTX||Vertex Pharmaceuticals Incorporated||20.45%||108.01||2.0%||$218.70m|
|KITE||Kite Pharma, Inc.||-0.13%||78.51||17.5%||$216.08m|
|ALXN||Alexion Pharmaceuticals, Inc.||1.85%||120.72||1.6%||$208.60m|
|ESPR||Esperion Therapeutics, Inc.||-2.44%||34.79||17.7%||$146.82m|
|CLVS||Clovis Oncology, Inc.||-3.98%||64.39||17.2%||$135.52m|
|AUPH||Aurinia Pharmaceuticals Inc.||1.96%||7.30||8.0%||$134.79m|
Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA.